Drug Profile


Alternative Names: Piroxicam cinnamate; Sinartrol; SPA S 510

Latest Information Update: 09 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SPA
  • Developer Bukwang Pharmaceutical; CJ Corporation; SPA
  • Class Nonsteroidal anti-inflammatories; Thiazines
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Rheumatic disorders

Most Recent Events

  • 23 Dec 2002 Cheil Jedang is now called CJ Corporation
  • 15 Feb 2001 Investigation in Rheumatic disorders in Europe (PO)
  • 20 Feb 1997 Launched for Rheumatic disorders in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top